A comprehensive in vitro and in silico assessment of eugenol glycoconjugates against azole and amphotericin B resistant Rhizopus spp.
Molecular Biology Reports · 2025
DOI: 10.1007/s11033-025-10673-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Pooja Sen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Biotechnology, Amity University Uttar Pradesh, Sector-125, Noida, Uttar Pradesh, 201301, India. Hauptthemen laut MEDLINE: Rhizopus, Eugenol, Glycoconjugates. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
BACKGROUND: Rhizopus spp. is a major cause of mucormycosis, a severe infectious disease with high morbidity and mortality. Treatment is challenging due to rising antifungal resistance. Glycosylation is a crucial technique for enhancing the properties of phenolic compounds like eugenol. The present study aims to examine the antifungal efficacy of eugenol glycoconjugates against azole and amphotericin B-resistant Rhizopus isolates. METHODS AND RESULTS: Out of 50 soil samples, 12 isolates belonging to Mucorales were obtained, of which 7 were identified as Rhizopus spp. via 18S ITS sequencing. Antifungal susceptibility testing (AST) revealed that all Rhizopus isolates were resistant to amphotericin B (MIC > 1 µg/mL). Most isolates also showed resistance towards posaconazole (MIC > 1 µg/mL) and itraconazole (MIC > 2 µg/mL). AST of eugenol glycoconjugate (coded 6g) showed efficacy against resistant Rhizopus isolates, with MIC values ranging from 6.25 µg/mL to 25 µg/mL. Flow cytometry confirmed its fungicidal activity, correlating with MIC data. Compound 6g significantly reduced conidial germination within 24 h and exhibited no cytotoxicity on A549 lung cancer cells. In-silico analysis revealed a negative binding affinity of compound 6g for the spore coat protein CotH3, which could be a potential antifungal target. CONCLUSION: Compound 6g could be an potential antifungal molecule against resistant Rhizopus spp, which requires further studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amity Institute of Biotechnology, Amity University Uttar Pradesh, Sector-125, Noida, Uttar Pradesh, 201301, India.
- Division of Organic Chemistry, CSIR-National Chemical Laboratory (CSIR-NCL), Dr. Homi Bhabha Road, Pune, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Amity Institute of Biotechnology, Amity University Uttar Pradesh, Sector-125, Noida, Uttar Pradesh, 201301, India. vrpooja@amity.edu.
Förderung
- Council of Scientific and Industrial Research, India
Zitieren
APA
Sen, P., Gupta, L., Chauhan, A., Goswami, L., Bhattacharya, A. K., Sengupta, A., & Vijayaraghavan, P. (2025). A comprehensive in vitro and in silico assessment of eugenol glycoconjugates against azole and amphotericin B resistant Rhizopus spp. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-10673-2
Vancouver
Sen P, Gupta L, Chauhan A, Goswami L, Bhattacharya AK, Sengupta A, et al. A comprehensive in vitro and in silico assessment of eugenol glycoconjugates against azole and amphotericin B resistant Rhizopus spp. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-10673-2
BibTeX
@article{Sen2025,
author = {Sen, Pooja and Gupta, Lovely and Chauhan, Aastha and Goswami, Lakshmi and Bhattacharya, Asish K and Sengupta, Abhishek and Vijayaraghavan, Pooja},
title = {A comprehensive in vitro and in silico assessment of eugenol glycoconjugates against azole and amphotericin B resistant Rhizopus spp},
journal = {Molecular Biology Reports},
year = {2025},
doi = {10.1007/s11033-025-10673-2}
}
EUVIMED